The global landscape of renal treatment is changing promptly. With the worldwide rise of chronic kidney disorder (CKD), hypertension, and diabetes, the pressure on nephrology departments, specialised dialysis centers, and transplant units has intensified noticeably. For B2B corporations—including professional medical device manufacturers of hemod